Symptom clusters in newly diagnosed glioma patients: which symptom clusters are independently associated with functioning and global health status?

被引:51
作者
Coomans, Marijke B. [1 ]
Dirven, Linda [1 ,2 ]
Aaronson, Neil K. [3 ]
Baumert, Brigitta G. [4 ,5 ,6 ]
Van Den Bent, Martin [7 ]
Bottomley, Andrew [8 ]
Brandes, Alba A. [9 ]
Chinot, Olivier [10 ]
Coens, Corneel [8 ]
Gorlia, Thierry [11 ]
Herrlinger, Ulrich [12 ]
Keime-Guibert, Florence [13 ]
Malmstroem, Annika [14 ,15 ]
Martinelli, Francesca [8 ]
Stupp, Roger [16 ]
Talacchi, Andrea [17 ]
Weller, Michael [18 ,19 ]
Wick, Wolfgang [20 ,21 ,22 ]
Reijneveld, Jaap C. [23 ,24 ]
Taphoorn, Martin J. B. [1 ,2 ]
机构
[1] Leiden Univ, Dept Neurol, Med Ctr, POB 9600, NL-2300 RC Leiden, Netherlands
[2] Haaglanden Med Ctr, Dept Neurol, The Hague, Netherlands
[3] Netherlands Canc Inst, Div Psychosocial Res & Epidemiol, Amsterdam, Netherlands
[4] Univ Hosp Bonn, Dept Radiat Oncol, Bonn, Germany
[5] Maastricht Univ, Med Ctr, MAASTRO Clin, Dept Radiat Oncol, Maastricht, Netherlands
[6] Maastricht Univ, Med Ctr, GROW Sch Oncol & Dev Biol, Maastricht, Netherlands
[7] Erasmus MC Canc Inst, Brain Tumor Ctr, Rotterdam, Netherlands
[8] European Org Res Treatment Canc, Qual Life Dept, Brussels, Belgium
[9] Azienda USL IRCCS, Inst Hospitalizat & Sci Care, Local Hlth Unit Co, Dept Med Oncol,Inst Neurol Sci, Bologna, Italy
[10] Aix Marseille Univ, Neurophysiopathol Inst, Univ Hosp Ctr Timone, Neurooncol Serv, Marseille, France
[11] European Org Res & Treatment Canc Headquarters, Brussels, Belgium
[12] Univ Bonn, Med Ctr, Dept Neurol, Div Clin Neurooncol, Bonn, Germany
[13] Pitie Salpetriere Hosp Grp, Paris, France
[14] Linkoping Univ, Dept Adv Home Care, Linkoping, Sweden
[15] Linkoping Univ, Dept Clin & Expt Med, Linkoping, Sweden
[16] Northwestern Univ, Feinberg Sch Med, Chicago, IL 60611 USA
[17] San Giovanni Addolorata Hosp, Dept Neurosci, Rome, Italy
[18] Univ Hosp, Dept Neurol, Zurich, Switzerland
[19] Univ Zurich, Zurich, Switzerland
[20] Univ Hosp Heidelberg, Neurol Clin, Heidelberg, Germany
[21] Univ Hosp Heidelberg, Natl Ctr Tumour Dis, Heidelberg, Germany
[22] German Canc Res Ctr, German Consortium Translat Canc Res, Clin Cooperat Unit Neurooncol, Heidelberg, Germany
[23] Univ Amsterdam, Med Ctr, Dept Neurol, Amsterdam, Netherlands
[24] Univ Amsterdam, Med Ctr, Brain Tumour Ctr Amsterdam, Amsterdam, Netherlands
关键词
EORTC QLQ-C30; glioma; health-related quality of life; QLQ-BN20; symptom; symptom cluster; QUALITY-OF-LIFE; TEMOZOLOMIDE CHEMOTHERAPY; EUROPEAN-ORGANIZATION; CLINICAL-TRIALS; CANCER-PATIENTS; OPEN-LABEL; RADIOTHERAPY; GLIOBLASTOMA; REHABILITATION; SURVIVAL;
D O I
10.1093/neuonc/noz118
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background. Symptom management in glioma patients remains challenging, as patients suffer from various concurrently occurring symptoms. This study aimed to identify symptom clusters and examine the association between these symptom clusters and patients' functioning. Methods. Data of the CODAGLIO project was used, including individual patient data from previously published international randomized controlled trials (RCTs) in glioma patients. Symptom prevalence and level of functioning were assessed with European Organisation for Research and Treatment of Cancer (EORTC) quality of life QLQ-C30 and QLQ-BN20 self-report questionnaires. Associations between symptoms were examined with Spearman correlation coefficients and partial correlation networks. Hierarchical cluster analyses were performed to identify symptom clusters. Multivariable regression analyses were performed to determine independent associations between the symptom clusters and functioning, adjusted for possible confounders. Results. Included in the analysis were 4307 newly diagnosed glioma patients from 11 RCTs who completed the EORTC questionnaires before randomization. Many patients (44%) suffered from 5-10 symptoms simultaneously. Four symptom clusters were identified: a motor cluster, a fatigue cluster, a pain cluster, and a gastrointestinal/seizures/bladder control cluster. Having symptoms in the motor cluster was associated with decreased (>= 10 points difference) physical, role, and social functioning (betas ranged from -11.3 to -15.9, all P < 0.001), independent of other factors. Similarly, having symptoms in the fatigue cluster was found to negatively influence role functioning (beta of -12.3, P < 0.001), independent of other factors. Conclusions. Two symptom clusters, the fatigue and motor cluster, were frequently affected in glioma patients and were found to independently have a negative association with certain aspects of patients' functioning as measured with a self-report questionnaire.
引用
收藏
页码:1447 / 1457
页数:11
相关论文
共 51 条
[1]   THE EUROPEAN-ORGANIZATION-FOR-RESEARCH-AND-TREATMENT-OF-CANCER QLQ-C30 - A QUALITY-OF-LIFE INSTRUMENT FOR USE IN INTERNATIONAL CLINICAL-TRIALS IN ONCOLOGY [J].
AARONSON, NK ;
AHMEDZAI, S ;
BERGMAN, B ;
BULLINGER, M ;
CULL, A ;
DUEZ, NJ ;
FILIBERTI, A ;
FLECHTNER, H ;
FLEISHMAN, SB ;
DEHAES, JCJM ;
KAASA, S ;
KLEE, M ;
OSOBA, D ;
RAZAVI, D ;
ROFE, PB ;
SCHRAUB, S ;
SNEEUW, K ;
SULLIVAN, M ;
TAKEDA, F .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1993, 85 (05) :365-376
[2]   Cancer Symptom Clusters: An Exploratory Analysis of Eight Statistical Techniques [J].
Aktas, Aynur ;
Walsh, Declan ;
Hu, Bo .
JOURNAL OF PAIN AND SYMPTOM MANAGEMENT, 2014, 48 (06) :1254-1266
[3]  
[Anonymous], 2013, IBM SPSS STAT WIND 2, V20
[4]  
[Anonymous], 2003, APPL STAT BEHAV SCI
[5]  
[Anonymous], 2014, MSOR CONNECTIONS
[6]   Determining priority signs and symptoms for use as clinical outcomes assessments in trials including patients with malignant gliomas: Panel 1 Report [J].
Armstrong, Terri S. ;
Bishof, Allison M. ;
Brown, Paul D. ;
Klein, Martin ;
Taphoorn, Martin J. B. ;
Theodore-Oklota, Christina .
NEURO-ONCOLOGY, 2016, 18 :1-12
[7]   The symptom burden of primary brain tumors: evidence for a core set of tumor- and treatment-related symptoms [J].
Armstrong, Terri S. ;
Vera-Bolanos, Elizabeth ;
Acquaye, Alvina A. ;
Gilbert, Mark R. ;
Ladha, Harshad ;
Mendoza, Tito .
NEURO-ONCOLOGY, 2016, 18 (02) :252-260
[8]   Symptom clusters in oncology patients and implications for symptom research in people with primary brain tumors [J].
Armstrong, TS ;
Cohen, MZ ;
Eriksen, LR ;
Hickey, JV .
JOURNAL OF NURSING SCHOLARSHIP, 2004, 36 (03) :197-206
[9]   DEFINING THE SYMPTOM CLUSTER: HOW FAR HAVE WE COME? [J].
Barsevick, Andrea .
SEMINARS IN ONCOLOGY NURSING, 2016, 32 (04) :334-350
[10]   Temozolomide chemotherapy versus radiotherapy in high-risk low-grade glioma (EORTC 22033-26033): a randomised, open-label, phase 3 intergroup study [J].
Baumert, Brigitta G. ;
Hegi, Monika E. ;
van den Bent, Martin J. ;
von Deimling, Andreas ;
Gorlia, Thierry ;
Hoang-Xuan, Khe ;
Brandes, Alba A. ;
Kantor, Guy ;
Taphoorn, Martin J. B. ;
Ben Hassel, Mohamed ;
Hartmann, Christian ;
Ryan, Gail ;
Capper, David ;
Kros, Johan M. ;
Kurscheid, Sebastian ;
Wick, Wolfgang ;
Enting, Roelien ;
Reni, Michele ;
Thiessen, Brian ;
Dhermain, Frederic ;
Bromberg, Jacoline E. ;
Feuvret, Loic ;
Reijneveld, Jaap C. ;
Chinot, Olivier ;
Gijtenbeek, Johanna M. M. ;
Rossiter, John P. ;
Dif, Nicolas ;
Balana, Carmen ;
Bravo-Marques, Jose ;
Clement, Paul M. ;
Marosi, Christine ;
Tzuk-Shina, Tzahala ;
Nordal, Robert A. ;
Rees, Jeremy ;
Lacombe, Denis ;
Mason, Warren P. ;
Stupp, Roger .
LANCET ONCOLOGY, 2016, 17 (11) :1521-1532